Literature DB >> 10801838

Runt domain factor (Runx)-dependent effects on CCAAT/ enhancer-binding protein delta expression and activity in osteoblasts.

T L McCarthy1, C Ji, Y Chen, K K Kim, M Imagawa, Y Ito, M Centrella.   

Abstract

Transcription factor CCAAT/enhancer-binding protein delta (C/EBPdelta) is normally associated with acute-phase gene expression. However, it is expressed constitutively in primary osteoblast cultures where it increases insulin-like growth factor I synthesis in a cAMP-dependent way. Here we show that the 3' proximal region of the C/EBPdelta gene promoter contains a binding sequence for Runt domain factor Runx2, which is essential for osteogenesis. This region of the C/EBPdelta promoter directed high reporter gene expression in osteoblasts, and specifically bound Runx2 in osteoblast-derived nuclear extract. C/EBPdelta gene promoter activity was reduced by mutating the Runx binding sequence or by co-transfecting with Runx2 antisense expression plasmid, and was enhanced by overexpression of Runx-2. Exposure to prostaglandin E(2) increased Runx-dependent gene transactivation independently of Runx2 binding to DNA. Runx2 bound directly to the carboxyl-terminal region of C/EBPdelta itself, and its ability to drive C/EBPdelta expression was suppressed when C/EBPdelta or its carboxyl-terminal fragment was increased by overexpression. Consistent effects also occurred on C/EBPdelta-dependent increases in gene expression driven by synthetic or insulin-like growth factor I gene promoter fragments. These interactions between Runx2 and C/EBPdelta, and their activation by prostaglandin E(2), provide new evidence for their importance during skeletal remodeling, inflammatory bone disease, or fracture repair.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2000        PMID: 10801838     DOI: 10.1074/jbc.M002291200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility.

Authors:  Marta E Alarcón-Riquelme
Journal:  Springer Semin Immunopathol       Date:  2006-09-09

Review 2.  Signaling and transcriptional regulation in osteoblast commitment and differentiation.

Authors:  Wei Huang; Shuying Yang; Jianzhong Shao; Yi-Ping Li
Journal:  Front Biosci       Date:  2007-05-01

Review 3.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 4.  Irradiation by high-intensity red light-emitting diode enhances human bone marrow mesenchymal stem cells osteogenic differentiation and mineralization through Wnt/β-catenin signaling pathway.

Authors:  Yaru Ruan; Hirohito Kato; Yoichiro Taguchi; Nobuhiro Yamauchi; Makoto Umeda
Journal:  Lasers Med Sci       Date:  2020-06-25       Impact factor: 3.161

5.  Stratified control of IGF-I expression by hypoxia and stress hormones in osteoblasts.

Authors:  Thomas L McCarthy; Zhong Yun; Joseph A Madri; Michael Centrella
Journal:  Gene       Date:  2014-01-15       Impact factor: 3.688

Review 6.  CCAAT/enhancer-binding proteins: structure, function and regulation.

Authors:  Dipak P Ramji; Pelagia Foka
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

Review 7.  Networks and hubs for the transcriptional control of osteoblastogenesis.

Authors:  Jane B Lian; Gary S Stein; Amjad Javed; Andre J van Wijnen; Janet L Stein; Martin Montecino; Mohammad Q Hassan; Tripti Gaur; Christopher J Lengner; Daniel W Young
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

8.  Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.

Authors:  Ya-Huei Kuo; Sayyed K Zaidi; Svetlana Gornostaeva; Toshihisa Komori; Gary S Stein; Lucio H Castilla
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

9.  Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.

Authors:  J A Mertz; F Mustafa; S Meyers; J P Dudley
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  Novel links among Wnt and TGF-beta signaling and Runx2.

Authors:  Thomas L McCarthy; Michael Centrella
Journal:  Mol Endocrinol       Date:  2010-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.